Publication | Open Access

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Patient SafetyGastroenterologyPharmacotherapyCns 7056MedicinePhase Iii StudyEmergency MedicineAnesthesiology